Baminercept in Sjögren's Syndrome - Full Text View - ClinicalTrials.gov

Baminercept in Sjögren's Syndrome - Full Text View - ClinicalTrials.gov

Visit us on the Web	Follow us on Twitter	Visit us on Facebook	Follow us on LinkedIn

Primary Sjögren's Syndrome Patients Needed for NIAID Clinical Trial
A new NIAID clinical trial is seeking patients ages 18 to 75 with primary Sjögren's syndrome to help evaluate the safety and effectiveness of an experimental treatment. The trial is being conducted at medical research facilities across the United States.
Visit clinicaltrials.gov for more information, full eligibility criteria, and study site locations (ClinicalTrials.gov identifier NCT01552681).